Starling Oncology, Inc.
STLN- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Starling Oncology, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −3 vs. Q3 2024
- Shares held
- 14.7M
- −5.88M (−28.5%) vs. Q3 2024
- Total value
- $4.61M
- −$2.12M (−31.5%) vs. Q3 2024
- New holders
- 5
- 9 more added
- Sold out
- 8
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $217.6M |
| Q1 2026 | 115 | $118.9M |
| Q4 2025 | 117 | $137.1M |
| Q3 2025 | 108 | $121.0M |
| Q2 2025 | 79 | $65.5M |
| Q1 2025 | 43 | $19.4M |
| Q4 2024 | 31 | $4.61M |
| Q3 2024 | 34 | $6.73M |
| Q2 2024 | 39 | $8.60M |
| Q1 2024 | 47 | $27.2M |
| Q4 2023 | 45 | $37.6M |
| Q3 2023 | 36 | $21.2M |
| Q2 2023 | 38 | $7.66M |
| Q1 2023 | 39 | $14.9M |
| Q4 2022 | 40 | $38.7M |
| Q3 2022 | 39 | $108.4M |
| Q2 2022 | 36 | $110.9M |
| Q1 2022 | 29 | $159.0M |
| Q4 2021 | 21 | $199.9M |
| Q3 2021 | 1 | $2.50M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital Advisors, Ltd. LLC | 1,219 | $0 | 0.00% | +1,219 | New |
| BNP Paribas Arbitrage, SA | 5 | $2 | 0.00% | +5 | New |
| JPMorgan Chase & Co | 166 | $51 | 0.00% | −5−2.9% | Reduced |
| Citigroup Inc | 634 | $196 | 0.00% | +609+2,436.0% | Added |
| Bank of America Corp | 2,918 | $902 | 0.00% | +211+7.8% | Added |
| AMG National Trust Bank | 10,000 | $3.09K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 13,540 | $4.18K | 0.00% | +4,741+53.9% | Added |
| Scientech Research LLC | 21,198 | $6.55K | 0.00% | +21,198 | New |
| Morgan Stanley | 30,392 | $9.39K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 37,250 | $11.5K | 0.00% | +12,141+48.4% | Added |
| UBS Group AG | 61,961 | $19.1K | 0.00% | +61,961 | New |
| Northern Trust Corp | 64,902 | $20.1K | 0.00% | 00.0% | Unchanged |
| Fielder Capital Group LLC | 70,192 | $21.7K | 0.01% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 81,362 | $25.1K | 0.00% | 00.0% | Unchanged |
| Lee Financial Co | 81,362 | $25.1K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 94,264 | $29.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 101,300 | $31.3K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 125,141 | $38.7K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 127,659 | $39.4K | 0.00% | +109,769+613.6% | Added |
| Virtu Financial LLC | 131,759 | $41.0K | 0.00% | +131,759 | New |
| Renaissance Technologies LLC | 182,000 | $56.2K | 0.00% | +12,000+7.1% | Added |
| BlackRock, Inc. | 253,591 | $78.4K | 0.00% | +651+0.3% | Added |
| FourWorld Capital Management LLC | 257,000 | $79.4K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 347,347 | $107.4K | 0.00% | −32,634−8.6% | Reduced |
| Quattro Financial Advisors LLC | 162,724 | $112.7K | 0.03% | 00.0% | Unchanged |
| FreeGulliver LLC | 600,747 | $185.6K | 0.10% | +412,578+219.3% | Added |
| Balyasny Asset Management LLC | 1,725,562 | $533.2K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,754,386 | $542.1K | 0.00% | −29,068−1.6% | Reduced |
| Cincinnati Insurance Co | 2,034,045 | $628.5K | 0.01% | 00.0% | Unchanged |
| Tiff Advisory Services Inc | 2,979,141 | $920.6K | 0.31% | +346,256+13.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 3,360,052 | $1.04M | 0.02% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −4,749,900−100.0% | Sold out |
| Kent Lake PR LLC | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −91,337−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −34,411−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −18,300−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,997−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,642−100.0% | Sold out |
| Boston Financial Mangement LLC | 0 | $0 | 0.00% | −2,679−100.0% | Sold out |